Assuming the latter, we can hypothesize that decreased methylation of BRSK2 may contribute to adverse neuronal development, neuronal maintenance, and dysregulated blood glucose levels which may explain the increased risk for diabetes and cardiovascular disease observed in prior PTSD studies [84, 85]. Here, BRSK2 is linked to post-traumatic stress disorder.